Ting‐Yu Lin

1.9k total citations
66 papers, 1.4k citations indexed

About

Ting‐Yu Lin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ting‐Yu Lin has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ting‐Yu Lin's work include RNA modifications and cancer (15 papers), RNA and protein synthesis mechanisms (12 papers) and RNA Research and Splicing (8 papers). Ting‐Yu Lin is often cited by papers focused on RNA modifications and cancer (15 papers), RNA and protein synthesis mechanisms (12 papers) and RNA Research and Splicing (8 papers). Ting‐Yu Lin collaborates with scholars based in Taiwan, Poland and United States. Ting‐Yu Lin's co-authors include Sebastian Glatt, Jonathan G. Heddle, Shwu‐Bin Lin, Cheng-Po Huang, Anna Biela, Otto S. Lin, Maw‐Soan Soon, Jin‐Yuan Shih, James Chih‐Hsin Yang and Tzu‐Hua Chang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ting‐Yu Lin

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ting‐Yu Lin Taiwan 21 686 299 141 133 109 66 1.4k
Xiangping Liu China 19 662 1.0× 220 0.7× 89 0.6× 253 1.9× 130 1.2× 95 1.3k
Chi‐Yuan Chen Taiwan 30 1.2k 1.8× 230 0.8× 150 1.1× 350 2.6× 221 2.0× 82 2.1k
Xiaolong Li China 20 617 0.9× 268 0.9× 91 0.6× 98 0.7× 268 2.5× 99 1.5k
Mario Schubert Germany 19 567 0.8× 325 1.1× 80 0.6× 166 1.2× 121 1.1× 54 1.6k
Ziheng Zhang China 18 645 0.9× 149 0.5× 199 1.4× 201 1.5× 75 0.7× 60 1.1k
Chunhong Li China 25 1.0k 1.5× 223 0.7× 137 1.0× 403 3.0× 179 1.6× 153 1.8k
Matteo Lulli Italy 23 737 1.1× 180 0.6× 105 0.7× 335 2.5× 90 0.8× 73 1.6k
Wen Jin Wu United States 26 1.2k 1.8× 760 2.5× 133 0.9× 108 0.8× 129 1.2× 62 2.3k
Qian Zeng China 21 498 0.7× 201 0.7× 126 0.9× 161 1.2× 179 1.6× 71 1.3k
Chen Ding China 24 899 1.3× 243 0.8× 97 0.7× 313 2.4× 183 1.7× 76 1.9k

Countries citing papers authored by Ting‐Yu Lin

Since Specialization
Citations

This map shows the geographic impact of Ting‐Yu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Yu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Yu Lin more than expected).

Fields of papers citing papers by Ting‐Yu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Yu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Yu Lin. The network helps show where Ting‐Yu Lin may publish in the future.

Co-authorship network of co-authors of Ting‐Yu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Yu Lin. A scholar is included among the top collaborators of Ting‐Yu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Yu Lin. Ting‐Yu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Chih‐Hung, et al.. (2025). Effect of chronic kidney disease on survival in patients with chronic obstructive pulmonary disease. Respiratory Medicine. 244. 108181–108181.
2.
Hsu, Chen‐Yang, Amy Ming‐Fang Yen, Ting‐Yu Lin, et al.. (2025). Hepatitis C Virus Infection Associated with Oral Potentially Malignant Disorder, Oral Cancer, and Liver Diseases: A Community-Based Cross-Sectional Study. Cancers. 17(22). 3695–3695. 1 indexed citations
3.
Biela, Anna, Jakub Nowak, Artur Biela, et al.. (2025). Determining the effects of pseudouridine incorporation on human tRNAs. The EMBO Journal. 44(13). 3553–3585. 5 indexed citations
4.
Wu, Haoming, et al.. (2024). Effects of staphylococcal enterotoxin and fungal sensitization on clinical outcomes of asthma. European journal of medical research. 29(1). 577–577. 1 indexed citations
5.
Jaciuk, Marcin, Michał Rawski, Paulina Indyka, et al.. (2024). Cryo-EM structures of the human Elongator complex at work. Nature Communications. 15(1). 4094–4094. 13 indexed citations
6.
Lin, Ting‐Yu, et al.. (2023). Assessing overdiagnosis of fecal immunological test screening for colorectal cancer with a digital twin approach. npj Digital Medicine. 6(1). 24–24. 11 indexed citations
7.
Lin, Ting‐Yu, et al.. (2023). Developing seasonal z-number regression for waste-disposal forecasting in a Taiwanese hospital. Applied Soft Computing. 152. 111196–111196. 2 indexed citations
8.
Biela, Anna, et al.. (2023). The diverse structural modes of tRNA binding and recognition. Journal of Biological Chemistry. 299(8). 104966–104966. 34 indexed citations
9.
Lin, Ting‐Yu, Robert Śmigiel, Bożena Kuźniewska, et al.. (2022). Destabilization of mutated human PUS3 protein causes intellectual disability. Human Mutation. 43(12). 2063–2078. 20 indexed citations
10.
Lin, Ting‐Yu, et al.. (2022). Different Characteristics and Clinical Outcomes between Early-Onset and Late-Onset Asthma: A Prospective Cohort Study. Journal of Clinical Medicine. 11(24). 7309–7309. 2 indexed citations
11.
Chakraborti, Soumyananda, Ting‐Yu Lin, Sebastian Glatt, & Jonathan G. Heddle. (2020). Enzyme encapsulation by protein cages. RSC Advances. 10(22). 13293–13301. 37 indexed citations
12.
Hsu, Ping‐Chih, Chun‐Chieh Wang, Chen‐Te Wu, et al.. (2019). Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study. Thoracic Cancer. 10(8). 1683–1691. 4 indexed citations
13.
Yang, Wan‐Yu, Ting‐Yu Lin, Hsing‐Pang Hsieh, et al.. (2019). Identification of Two Novel Small Compounds that Inhibit Liver Cancer Formation in Zebrafish and Analysis of Their Conjugation to Nanodiamonds to Further Reduce Toxicity. Advanced Therapeutics. 2(12). 10 indexed citations
14.
Kuo, Chih‐Hsi S., Chi‐Hsien Huang, Chien‐Ying Liu, et al.. (2019). Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib. Targeted Oncology. 14(4). 433–440. 10 indexed citations
15.
Kuo, Chih‐Hsi S., Chin‐Chou Wang, Yu‐Chen Huang, et al.. (2019). Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer. Thoracic Cancer. 10(5). 1158–1166. 19 indexed citations
16.
Li, Jiaqi, et al.. (2019). A Qualitative Exploration of STEM Career Development of High School Students in Taiwan. Journal of Career Development. 48(2). 120–134. 24 indexed citations
17.
Huang, Yu‐Chen, Chien‐Ying Liu, Stelios Pavlidis, et al.. (2018). Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR‐mutant and EGFR‐wild type nonsquamous non‐small cell lung cancer. Thoracic Cancer. 9(12). 1648–1655. 3 indexed citations
18.
19.
Lin, Ting‐Yu, et al.. (2014). Unique features of apicoplast DNA gyrases from Toxoplasma gondii and Plasmodium falciparum. BMC Bioinformatics. 15(1). 416–416. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangping Liu Breakdown of academic impact, for papers by Chi‐Yuan Chen Breakdown of academic impact, for papers by Xiaolong Li Breakdown of academic impact, for papers by Mario Schubert Breakdown of academic impact, for papers by Ziheng Zhang Breakdown of academic impact, for papers by Chunhong Li Breakdown of academic impact, for papers by Matteo Lulli Breakdown of academic impact, for papers by Wen Jin Wu Breakdown of academic impact, for papers by Qian Zeng Breakdown of academic impact, for papers by Chen Ding
Rankless by CCL
2026